Creating headroom: can cutting spend on low-value prescriptions fund new drugs?
Can reducing NHS spending on ‘low-value’ prescriptions help fund new drugs?
Can reducing NHS spending on ‘low-value’ prescriptions help fund new drugs?
Leela Barham examines the approach of the Institute for Clinical and Economic Review.
What could be the impact of proposed new ‘budget impact threshold’ for drugs?